aCL IgG |
37.09 |
100.00 |
60.58 |
0.371 |
100.00 |
48.65 |
∞ |
aCL IgM |
8.61 |
97.78 |
41.90 |
0.064 |
86.67 |
38.94 |
4.15(0.91-18.81) |
aCL IgG or IgM |
41.06 |
97.78 |
62.24 |
0.389 |
96.88 |
49.72 |
30.65(7.27-129.20) |
aβ2GpI IgG |
23.18 |
100.00 |
51.86 |
0.232 |
100.00 |
43.69 |
∞ |
aβ2GpI IgM |
7.95 |
98.89 |
41.91 |
0.068 |
92.31 |
39.04 |
7.68(0.98-60.12) |
aβ2GpI IgG or IgM |
29.14 |
98.89 |
55.19 |
0.28 |
97.78 |
45.41 |
36.60(4.94-270.96) |
aCL or aB2GpI IgG or IgM |
43.05 |
97.78 |
63.48 |
0.408 |
97.01 |
50.57 |
33.26(7.89-140.10) |
aCL IgA |
30.46 |
92.22 |
53.53 |
1.2268 |
86.79 |
44.15 |
5.19(2.23-12.10) |
aβ2GpI IgA |
6.62 |
98.89 |
41.08 |
1.0551 |
90.91 |
38.70 |
6.31(0.79-50.16) |
aCL IgG or IgM or IgA |
51.66 |
91.11 |
66.39 |
1.4277 |
90.70 |
52.90 |
10.95(4.96-24.21) |
aβ2GpI IgG or IgM or IgA |
31.79 |
97.78 |
56.43 |
1.2957 |
96.00 |
46.07 |
20.51(4.85-86.79) |
aCL or aB2GpI IgG or IgM or IgA |
53.64 |
91.11 |
67.63 |
|
91.01 |
53.95 |
11.86(5.37-26.22) |
P1 |
<0.001 |
0.031 |
0.052 |
|
|
|
|
P2 |
0.125 |
1.000 |
0.375 |
|
|
|
|
P3 |
<0.001 |
0.031 |
0.052 |
|
|
|
|
aPS/PT IgG |
18.54 |
96.67 |
47.72 |
0.152 |
90.32 |
41.43 |
6.60(1.95-22.40) |
aPS/PT IgM |
7.28 |
98.89 |
41.49 |
0.062 |
91.67 |
38.86 |
6.99(0.89-55.10) |
aPS/PT IgG or IgM |
24.50 |
95.56 |
51.03 |
0.201 |
90.24 |
43.00 |
6.99(2.40-20.32) |
aCL, aB2GpI, or aPS/PT IgG or IgM |
45.70 |
94.44 |
63.90 |
0.401 |
93.24 |
50.90 |
14.31(5.49-37.25) |
P1’ |
<0.001 |
0.625 |
<0.001 |
|
|
|
|
P2’ |
0.167 |
0.375 |
0.064 |
|
|
|
|
P3’ |
0.125 |
0.250 |
1.000 |
|
|
|
|
aAnxV IgG |
30.46 |
100.00 |
56.43 |
0.305 |
100.00 |
46.15 |
∞ |
aAnxV IgM |
16.56 |
96.67 |
46.47 |
0.133 |
89.29 |
40.85 |
5.75(1.69-19.70) |
aAnxV IgG or IgM |
39.07 |
96.67 |
60.58 |
0.358 |
95.16 |
48.60 |
18.60(5.62-61.53) |
aCL, aβ2GpI, or aAnxV IgG or IgM |
47.68 |
96.67 |
65.98 |
0.444 |
96.00 |
52.41 |
26.43(8.01-87.26) |
P1” |
0.648 |
1.000 |
0.503 |
|
|
|
|
P2” |
<0.001 |
0.500 |
0.007 |
|
|
|
|
P3” |
0.016 |
1.000 |
0.070 |
|
|
|
|